Dendritic cells in genetic immunization.
Both humoral and cellular immune responses are inducible by inoculation of naked plasmid DNA encoding a polypeptide antigen. This new vaccination protocol, known as genetic immunization, has been used to initiate protective immunity against a variety of infectious pathogens and tumors in experimental animals. Dendritic cells (DC) are thought to play at least three distinct roles in genetic immunization: (1) MHC class II-restricted presentation of antigens secreted by neighboring, transfected cells, (2) MHC class I-restricted "cross" presentation of antigens released by neighboring, transfected cells, and (3) direct presentation of antigens by transfected DC themselves. Several new technologies have been developed recently in an attempt to improve the overall efficacy of genetic vaccination, as well as to regulate the type and class of resulting immune responses. These technologies include modification of plasmid DNA, co-delivery of genes encoding immunoregulatory molecules, and DC targeting. We will overview some of these new technologies in genetic immunization.
Takashima
A
A
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas 75235-9069, USA.
Morita
A
A
D000276:Adjuvants, Immunologic / Q000235:genetics; D000818:Animals; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D007424:Intracellular Fluid / Q000276:immunology; D019444:Vaccines, DNA
D000276:Adjuvants, Immunologic; D019444:Vaccines, DNA